The effects of ACEIs and ARBs on multiple outcomes in type 2 diabetes patients….
Read More »Diabetes In Control
Prevalence of Diabetic Ketoacidosis at Diagnosis
A recent analysis of youth with type 1 or type 2 diabetes shows that the incidence of DKA continues to be high….
Read More »Negative Outcomes Associated with Inter-arm Systolic Blood Pressure Differences in Diabetes Patients
Inter-arm systolic blood pressure differences may be a sign of bad things to come….
Read More »Standard Tests Can Miss Pediatric Diabetic Neuropathy
Noninvasive methods for screening pediatric patients with type 1 diabetes for peripheral diabetic neuropathy (DN) have low sensitivity, according to a systematic review….
Read More »Greatest Contributor to Diabetes: Obesity or Sugar?
Results of a recent large epidemiological study suggest that it is amount of dietary calories from sugar that plays the most pivotal role in diabetes risk….
Read More »Perfect OB Wheel
Evan Schoenberg $1.99/iOS Simple, fast, yet more thorough than any other pregnancy wheel available for the iPhone, Perfect OB Wheel is better than just a replacement for your trusty paper wheel. Features include: input flexibility and speed, thorough results, accurate results.
Read More »Letter from the Editor #725
This past week I was in the corporate office of one of the most successful ACO’s in the country meeting with members of their diabetes initiative project. As you know, improvement in A1c’s is a major grading point for 5-star quality ratings and this group has been charged with lowering …
Read More »SGLT2 Inhibition: A Novel Treatment Strategy for Type 2 Diabetes
In this special feature for our series on SGLT2 inhibitors, we are extremely pleased to present this comprehensive slide series from the WorldWIDE Initiative for Diabetes Education. In this subset of their series, the Role of the Kidneys is examined and the effects of SGLT2 inhibitors is explained….
Read More »Special Edition, SGLT2 Inhibitors, April 2014
The role of the kidneys are becoming very well known in the Ominous Octet of Diabetes. The SGLT2 receptor on the kidneys is a new target for novel treatments of diabetes. This month we have a set of very well done slides from the Worldwide Initiative for Diabetes Education that …
Read More »Editor’s Note, DCMS #184
How would you feel if your 85-year-old mother or grandmother got a call from her hospital that she needed to get an HIV and hepatitis test? This might have happened to her if she was one of over 4,200 patients in a Long Island hospital where they found…. Click here …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.